Data Integration Is the Linchpin

If you want to understand why most omnichannel strategies underperform, follow the data. In a typical pharma commercial organization, customer data lives in a CRM. Engagement data lives in a marketing automation platform. Claims data lives somewhere else. Field activity is tracked in yet another system. Digital behavior, media exposure, speaker program attendance, and patient support enrollment are often captured in their own corners of the enterprise.

The result is that no one has a complete picture of the customer. And if you do not have a complete picture, you certainly can’t deliver an orchestrated, seamless, coherent experience.

Data integration is the process of bringing these sources together into a unified view, resolving identity and behavior across channels and systems, and making that view actionable. It is what separates data accumulation from data activation.

This distinction matters more than it gets credit for. Many organizations have accumulated enormous amounts of customer data. They have invested in data warehouses and reporting dashboards and, in some cases, believed customer data platforms would solve the integration problem. But accumulating data and activating it are not the same thing. Activation means that data leads to insights, and those insights reach the right people and systems at the right time to influence what happens next in the customer journey. That requires more than storage or a new platform purchase. It requires architecture, governance, and organizational will.

Here is the uncomfortable part: most pharma leaders can recite these integration challenges from memory. The diagnosis is not the problem.

The challenge is that closing the gap requires making decisions that are organizationally difficult or uncomfortable: retiring systems that individual business units are attached to, forcing teams with different reporting lines to share data ownership, and committing to infrastructure investment that does not produce a clear marketable output. Those decisions require executive cover and cross-functional alignment that many organizations struggle to sustain.

The integration challenges also include legacy systems that were not built to talk to each other, data governance constraints that limit what can be linked and how, and interoperability across vendors that remains inconsistent despite years of progress. None of these are insurmountable. But they do require a deliberate strategy rather than a tool purchase.

What Fragmentation Actually Costs

The consequences of poor data integration are often obvious to the people receiving the engagement, even if they are invisible to the teams producing it.

Consider a common scenario. An HCP who has been an early adopter of a given therapy gets a rep visit reinforcing the clinical basics she figured out two years ago. That same week, she receives an email with an introductory offer for a patient support program she already enrolled her patients in. Then, a programmatic ad surfaces reminding her to “ask your rep about” the same drug. She’s left feeling that the brand is out of touch with her, perhaps even pestered, and she starts disengaging from the brand.

This is not a hypothetical edge case. It is what happens when channel teams operate independently and customer data is not shared. The brand may hit its activity targets while actively degrading relationships. And critically, the patient who might have benefited from that support program never gets the right touchpoint at the right moment because the engagement was not coordinated or timely.

Beyond the customer experience problem, fragmentation creates real financial waste. Media spend is poorly targeted when audience data is stale or siloed. Outreach is duplicated. Sales and marketing work from different versions of the customer, which leads to mistimed engagement and conflicting signals. Measurement becomes nearly impossible because you cannot attribute outcomes across channels when the channels do not share a common data foundation.

The cost of fragmentation is not just a bad customer experience. It is misallocated investment, missed commercial opportunity, and patients who do not access the therapy or support they need because the engagement model was not built around them.

Measuring Maturity: A Different Set of KPIs

One of the clearest signs that an organization is stuck in a channel-centric model is what it measures—open rates, click-through rates, rep call volume, email deployment counts—these metrics tell you whether the machinery is running. They do not tell you whether the engagement is working.

The more revealing question to ask is: can your organization close the loop between a specific digital touchpoint and a downstream prescribing event? For most pharma commercial teams, the honest answer is no. Not because the data does not exist, but because the systems that capture digital engagement and the systems that capture field and claims data have never been connected in a way that enables attribution. That attribution gap is a direct consequence of integration failure, and it means that most budget allocation decisions are still being made on assumption rather than evidence.

Omnichannel maturity requires a shift to journey-based and outcome-based measurement. The questions change from “How many emails did we send?” to “How are HCPs progressing through the adoption journey?” and “What combination of touchpoints is associated with the outcomes we care about?”

Summary: A Data Challenge Wearing a Marketing Hat

Omnichannel maturity is not primarily a marketing challenge. It is a data challenge that ends up manifesting itself in marketing outcomes, or a lack thereof.

The organizations that frame it as a marketing problem often keep buying or changing channels and platforms. The organizations that frame it as a data problem start building the infrastructure that makes those channels and platforms actually work together. And the organizations that connect it to patient outcomes, not just marketing performance, tend to find the alignment and sustained investment that the work actually requires.

The path forward is a clear-eyed look at the data architecture, the governance model, the content approval process, and the organizational alignment that either enables or limits everything else.

The ultimate measure of success is not marketing performance. It is whether the right HCP is having the right conversation at the right time, and whether the right patient is getting access to the right therapy. That outcome requires more than good creative and broad channel coverage. It requires integrated data, a governance model built for personalization, and the organizational discipline to use both well.

Part 2 of a two-part series. Part 1, “The Omnichannel Promise: Why Maturity Starts With Integration” by Jesse Pease, EVP, Innovation and Customer Solutions, argued that the gap between omnichannel as a concept and omnichannel as a lived experience is not primarily a channel problem. It is a data problem. This piece picks up where that one left off: what data integration actually means, what fragmentation costs an organization when it goes unsolved, and how to measure whether you are making real progress.

https://deerfieldgroup.com/news/the-omnichannel-promise